COVID-19 Health Evidence Summary No.51 by Millington, Kerry & Reddin, Samantha
   
1 
Evidence Summary 
y 
 
 
COVID-19  
Health Evidence Summary No.51 
Kerry Millington & Samantha Reddin 
Liverpool School of Tropical Medicine (LSTM) & Institute of Development Studies 
01 June 2020  
 
This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
 
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
29.05.2020 Neuropathogenesis 
and neurologic 
manifestations of 
the coronaviruses 
in the age of 
coronavirus 
disease 2019: A 
Review 
JAMA 
Neurology | 
Review 
 MERS-CoV and 
SARS-CoV-1 are 
known to cause 
disease in the 
central and 
peripheral nervous 
systems 
 The pulmonary 
manifestations of 
C19 have been well 
described in the 
literature but 
emerging evidence 
suggests C19 has 
neurologic 
consequences as 
well 
 This review 
summarises 
available 
information 
regarding 
neurological 
disorders 
 Morbidity | 
Neurological 
2 
associated with 
C19  which may 
lead to improved 
clinical outcomes 
and better treatment 
algorithms. This 
review also 
highlights where 
further studies are 
required  
29.05.2020 Mortality and 
pulmonary 
complications in 
patients undergoing 
surgery with 
perioperative 
SARS-CoV-2 
infection: an 
international cohort 
study 
The Lancet | 
Article 
 Analysis of 1128 
patients who had 
surgery between 1 
Jan and 31 Mar 
2020 
 Postoperative 
pulmonary 
complications occur 
in half of patients 
with perioperative 
SARS-CoV-2 
infection and are 
associated with high 
mortality 
 Thresholds for 
surgery during the 
C19 pandemic 
should be raised 
compared to normal 
practice, especially 
in men aged 70 
years and older 
 Postponing non-
urgent procedures 
and promoting non-
operative treatment 
to delay or avoid the 
need for surgery 
should be 
considered  
 Mortality | 
surgery 
29.05.2020 Clinical 
characteristics and 
risk factors 
associated with 
COVID-19 disease 
severity in patients 
with cancer in 
Wuhan, China: a 
multicentre, 
retrospective, 
cohort study 
The Lancet 
Oncology | 
Article 
 Patients with cancer 
and COVID-19 were 
more likely to 
deteriorate into 
severe illness than 
those without 
cancer 
 Risk factors 
identified in this 
study may help 
early clinical 
surveillance of 
disease progression 
of C19 in patients 
with cancer 
Morbidity | 
NCD 
3 
29.05.2020 Clinical 
characteristics, 
outcomes, and risk 
factors for mortality 
in patients with 
cancer and COVID-
19 in Hubei, China: 
a multicentre, 
retrospective, 
cohort study 
The Lancet 
Oncology | 
Article 
 Patients with cancer 
and COVID-19 
admitted to hospital 
had a high case-
fatality rate  
 Unfavourable 
prognostic factors, 
including receiving 
chemotherapy 
within 4 weeks 
before symptom 
onset and male sex, 
may help clinicians 
identify patients at 
high risk of dying 
Mortality | 
NCD 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
30.05.2020 Early transmission 
of SARS-CoV-2 in 
South Africa: an 
epidemiological and 
phylogenetic report 
medRxiv | 
Preprint (not 
peer 
reviewed) 
 A molecular epidemiological study 
by a network of government and 
university laboratories of the first 
21 SARS-CoV-2 whole genomes 
sampled in the first port of entry, 
KwaZulu-Natal (KZN) during the 
first month of the epidemic 
 The early introduction of SARS-
CoV-2 in KZN included a localised 
hospital outbreak which may 
explain the initially high death 
rates in the province 
 The current high rate of 
transmission of C19 in the 
Western Cape and Eastern Cape 
highlights the need to strengthen 
local genomic surveillance in SA 
 
  
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
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 29.05.2020 Rapid 
assessment 
of service 
delivery for 
NCDs during 
the COVID-
19 pandemic 
 WHO NCD 
Department | 
Preliminary 
results 
 A survey run by WHO with 
responses from 155 
countries has shown that 
C19 significantly impacts 
health services for cancer, 
cardiovascular disease 
and diabetes 
 Countries must find 
innovative ways to 
continue essential health 
services 
Health 
service | 
NCD 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
29.05.2020 Behavioural 
health and 
response for 
COVID-19 
Disaster 
Medicine and 
Public Health 
Preparedness 
 Research suggests that 
behavioural health 
concerns should take a 
primary role in response 
to the pandemic 
 A four-step services 
system is proposed 
designed for 
implementation with a 
variety of different groups 
and reserves limited 
clinical services for the 
most extreme reactions 
Behaviour 
22.05.2020 COVID-19 
pandemic, 
socioeconomic 
crises and 
human stress 
in resource-
limited settings: 
A case from 
Bangladesh 
Cell | 
Research 
Article 
 Study to understand 
the public perception 
of socioeconomic 
crises and human 
stress in resource-
limited settings of 
Bangladesh during 
the C19 outbreak 
 1066 Bangladeshi 
participants  
 Mental 
health 
  
5 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
01.06.2020 Covid-19 and health: five expert 
views 
ODI | Blog Emma Samman 
Tom Hart 
Fiona Samuels 
Carmen Leon-
Himmelstine 
Vidya Diwakar 
May 2020 Towards universal health 
systems in the Covid-19 era: 
opportunities and threats 
ODI | Briefing paper Emma Samman 
29.05.2020 All eyes are on local 
humanitarian responders during 
Covid-19 – now they need 
support 
ODI | Comment John Bryant 
01.06.2020 COVID-19 significantly impacts 
health services for 
noncommunicable diseases 
WHO | News release  
29.05.2020 The South African Response to 
the Pandemic 
NEJM | Correspondence Salim S. Abdool 
Karim 
29.05.2020 The right to health must guide 
responses to COVID-19 
The Lancet | Comment Dainius Puras 
Judith Bueno de 
Mesquita 
Luisa Cabal  
Allan Maleche 
Benjamin  Mason 
Meier 
6 
29.05.2020 Lockdown poses new 
challenges for cancer care in 
India 
The Lancet Oncology | 
News 
Dinesh C. Sharma 
29.05.2020 Poor clinical outcomes for 
patients with cancer during the 
COVID-19 pandemic 
The Lancet Oncology | 
Comment 
Liang V Tang 
Yu Hu 
27.05.2020 Tracking the genomic footprints 
of SARS-CoV-2 transmission 
Cell | Spotlight Tommy Tsan-Yuk 
Lam 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
& policy 
maps 
Current 
research 
including trials 
  Diagnosti
cs 
  Treatment
s 
  Vaccin
es 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-
CoV-2 Test 
Tracker 
  Global 
COVID-19 
Clinical 
Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-
CoV-2 
Diagnostic
s: 
performanc
e data 
  US NIH 
registered 
clinical 
trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based 
tests for 
COVID-19 
  Solidarity 
trial 
 COVID-
19 
Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford 
C19 
Governme
nt 
Response 
US NIH  Our World 
in Data: 
C19 
Testing 
  COVID-
19 
Therapeuti
  
7 
Tracker 
(OxCGRT) 
cs 
Accelerator 
Our World 
in Data 
  Singapor
e 
 Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 
5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltrials.g
ov 
      
Humanitari
an Data 
Exchange 
       UKCDR       
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
  
8 
C19 Resource Hubs 
Global  Regional 
& Country 
Academi
c 
journals 
& 
Publisher
s 
Institutes/Centres/Funders/
Other 
Health 
Topics 
  Social 
Sciences 
WHO 
COVID-19 
pandemic  
Africa 
CDC 
Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicati
on 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin 
of the 
WHO 
ICL MRC Centre for Global 
Infectious Disease Analysis  
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambrid
ge 
Universit
y Press 
ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell 
Press 
Johns Hopkins University RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy 
of 
Sciences 
Cochran
e  
Center for Global 
Development 
    Social 
Developm
ent Direct 
C19 blog 
series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID Repository     
9 
UNOCHA OCHA 
Southern 
and 
Eastern 
Africa 
COVID-19 
Digest 
JAMA 
Network 
Norwegian Institute of 
Public Health 
    
UNHCR  South 
African 
Governme
nt 
The 
Lancet 
Oxford Centre for 
Evidence-based Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprint
s) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
Universit
y Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources and 
Analyses of C19 Impact 
    
World Bank   Science  Prevent Epidemics      
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David 
Nabarro 
  SSRN 
(Preprint
s)  
      
Reliefweb   Wiley       
10 
Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global 
Impact Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 
Virtual event 1h 15 ODI 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
04.06.2020 
12pm ET 
CGD Conversations 
on COVID-19 and 
Event   CGD 
11 
Development: John 
Nkengasong 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
12 
coronavirus disease 
outbreak 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
13 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
